Development and verification of the PAM50-based Prosigna breast cancer gene signature assay - Wikidata - awgldk - TriplyDB

Development and verification of the PAM50-based Prosigna breast cancer gene signature assay

Development and verification of the PAM50-based Prosigna breast cancer gene signature assay

http://www.wikidata.org/entity/Q35752868

about

Hormonal Modulation of Breast Cancer Gene Expression: Implications for Intrinsic Subtyping in Premenopausal Women Limitations in predicting PAM50 intrinsic subtype and risk of relapse score with Ki67 in estrogen receptor-positive HER2-negative breast cancer.Improved prediction of PARP inhibitor response and identification of synergizing agents through use of a novel gene expression signature generation algorithm Translating RNA sequencing into clinical diagnostics: opportunities and challenges.Comparison of triple-negative breast cancer molecular subtyping using RNA from matched fresh-frozen versus formalin-fixed paraffin-embedded tissue.Chromatin Regulators as a Guide for Cancer Treatment Choice Prognostic Value of a BCSC-associated MicroRNA Signature in Hormone Receptor-Positive HER2-Negative Breast Cancer.Consensus of gene expression phenotypes and prognostic risk predictors in primary lung adenocarcinoma.Different prognosis of young breast cancer patients in their 20s and 30s depending on subtype: a nationwide study from the Korean Breast Cancer Society.NanoString, a novel digital color-coded barcode technology: current and future applications in molecular diagnostics.Integrating RNA sequencing into neuro-oncology practice.An mRNA Gene Expression-Based Signature to Identify FGFR1-Amplified Estrogen Receptor-Positive Breast Tumors.Internet tools to enhance breast cancer care.ESR1 and PGR polymorphisms are associated with estrogen and progesterone receptor expression in breast tumors.Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy.Male breast cancer: correlation between immunohistochemical subtyping and PAM50 intrinsic subtypes, and the subsequent clinical outcomes.Use of 21-gene recurrence score assay to individualize adjuvant chemotherapy recommendations in ER+/HER2- node positive breast cancer-A National Cancer Database study.Optimization of RNA Extraction from Formalin-Fixed Paraffin-Embedded Blocks for Targeted Next-Generation Sequencing.Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up.Intra-tumor heterogeneity in breast cancer has limited impact on transcriptomic-based molecular profiling.microRNA Expression in Ethnic Specific Early Stage Breast Cancer: an Integration and Comparative Analysis.Tissue-based biomarkers in prostate cancer.The ability of PAM50 risk of recurrence score to predict 10-year distant recurrence in hormone receptor-positive postmenopausal women with special histological subtypes.Upper Respiratory Symptoms, Gut Health and Mucosal Immunity in Athletes.Treg depletion potentiates checkpoint inhibition in claudin-low breast cancer.Development of a NanoString assay to detect leukemogenic fusion transcripts in acute myeloid leukemia.BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy.Integrated RNA and DNA sequencing reveals early drivers of metastatic breast cancer.RNA Oncoimmune Phenotyping of HPV-Positive p16-Positive Oropharyngeal Squamous Cell Carcinomas by Nodal Status.Developing a genetic signature to predict drug response in ovarian cancer.Mutational signatures and mutable motifs in cancer genomes.AR negative triple negative or "quadruple negative" breast cancers in African American women have an enriched basal and immune signature.TGFβ signaling limits lineage plasticity in prostate cancer.High-accuracy determination of internal circadian time from a single blood sample Luminal A Breast Cancer and Molecular Assays: A Review An Effect of Culture Media on Epithelial Differentiation Markers in Breast Cancer Cell Lines MCF7, MDA-MB-436 and SkBr3 Microenvironmental immune cell signatures dictate clinical outcomes for PTCL-NOS

P2860

Q28077637-294174A8-33F8-4213-ADA4-FC3314BF7A6F Q33591751-07BB1103-4842-46EC-8D02-D2AEA92C3460 Q33731278-BEA48DE4-574D-430E-AC80-A379CCB73704 Q34519034-FB4FB6E2-F337-4604-B9C9-A30B03F4E5C0 Q36334470-8881E4D3-BCB3-41DA-9187-9D25EA94B764 Q37075234-98C30998-9695-4218-8EF4-21417D03EADD Q37309678-2509F1C1-FFEB-4C0C-A78B-F5ED6374E652 Q37619692-481D643D-1136-4B97-A0DF-CD87C0C5422B Q38399507-A5A1EA0C-92B9-4D0D-878C-5CE71810C7CC Q38787248-612F0574-88C3-44AF-846A-43081D5D3A02 Q39459649-AA88B810-8B2B-4953-8954-9A354B9A77BE Q40417660-360CCEC7-647E-42F8-B58D-D734D5674740 Q42334186-95E9A1E8-C709-4F1F-9A30-42BC8014B90B Q42367688-8271F038-B550-4C39-9C29-C538FA23D45A Q42509592-B0BFA6C7-012E-4046-9B12-2A6E6DE87B4E Q42516409-CD71BC2A-61AA-4C0D-A912-32FA93D7B929 Q42670058-9153D29E-F1AE-4941-9131-61EE02103A30 Q47093527-E04D2E16-7B2A-48A9-9E18-E9F6708E36E0 Q47122813-1BE14215-F22D-4280-AAF3-8EF52B52B34A Q47140684-E423A3B6-58B6-4F3D-8018-BBD85ACEB783 Q47142555-4FE49058-06D7-43CB-908E-E7D20A6F8D54 Q47144748-F1C77333-9AD8-424E-B2CD-279DE316BC28 Q47372771-22E51C3E-090C-4A62-9376-8F3D79BDBA20 Q47649326-9B30B549-8293-45BA-8DA1-B8246A555C70 Q47927802-A9364D1F-60F6-4F2E-AD79-6C94C42103DB Q48142237-13838189-E2E3-4EAD-9B49-38DB1047FD9A Q48371625-C024D387-E1FC-4D58-88C9-2346C2E08C4C Q52372957-2C0D75CE-F1BD-4B90-84AC-1142F3D1CF56 Q52715554-0705BAFF-CD6C-4DDC-8FDE-5E542A44F17C Q55028564-705A07C1-AAC6-4104-A555-E4820681F23C Q55060101-84BD755D-F516-438E-A0C1-B99E0EB97BE9 Q55425855-B22438DC-BC74-46A5-904D-D328DE66C13F Q55461727-E142376D-3CC8-45E5-BC94-12A85CA048EF Q56965075-7299BCCA-EBBE-43AA-BFB9-5B142CD77F52 Q57113322-57ED8621-B077-4352-B201-899975B20D04 Q57825986-2158364E-13E6-425F-9386-2F88EA22AD1E Q58759110-CCCD1D98-9409-4C57-93B9-0F6D011932AD

P2860

Development and verification of the PAM50-based Prosigna breast cancer gene signature assay

http://www.wikidata.org/entity/Q35752868

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Development and verification o ...... st cancer gene signature assay

@ast

Development and verification o ...... st cancer gene signature assay

@en

type

label

Development and verification o ...... st cancer gene signature assay

@ast

Development and verification o ...... st cancer gene signature assay

@en

prefLabel

Development and verification o ...... st cancer gene signature assay

@ast

Development and verification o ...... st cancer gene signature assay

@en

P1433

Q35752868-F277021C-503D-4830-8BC9-DAD5CD6431A2

P1476

Q35752868-54A15034-CF22-4A35-9636-06DCCBD648F3

P2093

Q35752868-0447B3D5-F761-4894-9276-20C03125FAD3

Q35752868-0A342CFC-FB84-4758-89F9-9227E43AEFE6

Q35752868-361BC2B7-9FCA-4A4B-99F2-122CB19963AD

Q35752868-45859DA5-1A33-480D-B4C8-44A93B993163

Q35752868-4D1B82DE-9E90-4BB7-A1F0-762DD4EE63FB

Q35752868-7FE4549B-2D24-4AA2-A220-E4543935C201

Q35752868-8CA192EB-7D56-4C58-9D2A-58CB7107E4D6

Q35752868-918FC5E0-B355-451C-87EC-FB72A24299C3

Q35752868-A788EBD7-8756-40AC-A3F0-AB89FAB37C65

Q35752868-A8AC0B04-55C4-4278-BAB9-F46E1736CA50

P2860

Q35752868-0240D524-1B99-4472-9CFD-FEBFAE7F412E

Q35752868-046E8D6B-BE8D-44F0-BE73-7DEAADB3F1E9

Q35752868-0C9CA771-DB50-4F26-A67F-CE3A68ABA7A9

Q35752868-12A7C390-CA37-49BB-8EE9-48B488001365

Q35752868-19135372-D85B-46D4-9395-5AABA4AAFBF4

Q35752868-1C0901FC-0F16-474D-BD85-55CBC73C5BB5

Q35752868-22B72AC1-6E4C-449E-BEF2-B6D86AC371FD

Q35752868-245CD140-AEF3-475F-993B-0DBE77F42E79

Q35752868-2BB98CE7-852A-492A-B995-27234A90FA38

Q35752868-3134D449-FF30-42F9-9ED8-48D580CEA4AC

P2888

Q35752868-C3F2301A-443E-4462-BD90-AF38F17779D7

P304

Q35752868-18652232-1BC8-4B81-BF52-BBED72082CC8

P31

Q35752868-ADA02BB4-6E14-4968-BAB5-F3DFBADD1983

P356

Q35752868-48DAA835-14C7-41EE-98D0-66C4EAEE1287

P478

Q35752868-90E0DBAE-233D-4BD3-A6C6-7D11F4EEE244

P50

Q35752868-0AC3BA5B-01A3-4774-A171-F7E210B09440

Q35752868-5DB8E473-5029-4A2C-B3EE-DE40CCD7BB0A

P577

Q35752868-2EB61A0E-7086-4717-9471-C773521D9B8A

P5875

Q35752868-D76222D9-E768-4B62-BDE6-A6D74A38F672

P6179

Q35752868-A9F26FED-4F5C-43FD-9E08-61224B931CD4

P698

Q35752868-3DFE2BA0-E3CF-4EBA-A8C3-88EA1D427BDE

P932

Q35752868-FDE39947-6564-4840-8E96-8DF04B5C057E

P356

S12920-015-0129-6

P1433

BMC Medical Genomics

P1476

Development and verification o ...... st cancer gene signature assay

@en

P2093

Brett Wallden

http://www.w3.org/2001/XMLSchema#string

Carl Schaper

http://www.w3.org/2001/XMLSchema#string

Elaine R Mardis

http://www.w3.org/2001/XMLSchema#string

Gary Geiss

http://www.w3.org/2001/XMLSchema#string

Ivana Sestak

http://www.w3.org/2001/XMLSchema#string

Jacqueline Snider

http://www.w3.org/2001/XMLSchema#string

James Storhoff

http://www.w3.org/2001/XMLSchema#string

Joel S Parker

http://www.w3.org/2001/XMLSchema#string

Matthew J Ellis

http://www.w3.org/2001/XMLSchema#string

Michael Gnant

http://www.w3.org/2001/XMLSchema#string

P2860

Statistical modeling for selecting housekeeper genes

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

A gene-expression signature as a predictor of survival in breast cancer

Molecular portraits of human breast tumours

Repeated observation of breast tumor subtypes in independent gene expression data sets

Clinical application of the 70-gene profile: the MINDACT trial

Intraclass correlations: uses in assessing rater reliability

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

Direct multiplexed measurement of gene expression with color-coded probe pairs

Supervised risk predictor of breast cancer based on intrinsic subtypes

P2888

s12920-015-0129-6

P304

54

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12920-015-0129-6

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Charles M. Perou

Sherri R Davies

P577

2015-08-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281553745

http://www.w3.org/2001/XMLSchema#string

P6179

1049182276

http://www.w3.org/2001/XMLSchema#string

P698

26297356

http://www.w3.org/2001/XMLSchema#string

P932

4546262

http://www.w3.org/2001/XMLSchema#string